Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR.
about
Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Data driven polypharmacologica ...... targeting ALK, MET, and EGFR.
@en
Data driven polypharmacologica ...... targeting ALK, MET, and EGFR.
@nl
type
label
Data driven polypharmacologica ...... targeting ALK, MET, and EGFR.
@en
Data driven polypharmacologica ...... targeting ALK, MET, and EGFR.
@nl
prefLabel
Data driven polypharmacologica ...... targeting ALK, MET, and EGFR.
@en
Data driven polypharmacologica ...... targeting ALK, MET, and EGFR.
@nl
P2093
P2860
P1476
Data driven polypharmacologica ...... r targeting ALK, MET, and EGFR
@en
P2093
Franz X E Gruber
Osman A B S M Gani
Richard A Engh
P2860
P2888
P356
10.1186/S13321-017-0229-8
P577
2017-07-04T00:00:00Z
P6179
1090346964